Events

Moving Faster Toward the Clinic: Inside Biotech’s New Era of IND Readiness

From CMC strategy and analytics to CDMO partnerships and AI-enabled operations, life sciences ecosystem gathered at Propel Labs to discuss the growing pressure to execute with speed and precision. The biotech industry is entering a new phase where breakthrough science alone is no longer enough to attract capital, reach the clinic, or survive long enough […]

Featured News

Latest News

Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations

Financing extension led by 8VC to advance LTS-201 as a potential significant commercial opportunity in Huntington’s disease (IND expected in 3Q 2026) Potential clinical proof-of-concept of Latus platform from LTS-101 in CLN2 disease expected in 4Q 2026; multiple fast follow-ons utilize the same capsid for larger indications Proprietary engineered AAV capsids combined with optimal routes […]

A Night of Sharing Successes and Uplifting Women in Life Sciences

The 8th Annual Women in Bio HERstory Gala 2026 brought together professionals across the life sciences field to celebrate leadership, community, and the women shaping the future of the industry.  Women in Bio (WIB) is a global organization dedicated to advancing women in the life sciences through leadership skill development, mentorship, and community building.  The […]

Why Global Health Startups Are Entering the U.S. More Prepared Than Ever

Breaking into the U.S. healthcare market has traditionally been a slow, uncertain process for international companies, marked by regulatory complexity, fragmented systems, and long commercialization timelines. But at the WorldUpstart Winter Showcase in Philadelphia on April 27, a different pattern began to take shape. The companies in the room weren’t there to explore the U.S. […]

Analytics Now defines speed in Biopharma

Joe Newcome, Minaris Advanced Testing, on why release testing is setting the pace. Introduction In advanced therapies, speed is often framed in terms of manufacturing—how quickly a product can be produced, scaled, and delivered. But before any therapy reaches a patient, there is another step that ultimately determines how fast that process can move: release. […]

Analytics Is the New Bottleneck in Gene Therapy

Andrea Moore, AskBio, on why measurement—not discovery—is now the constraint. In gene therapy, innovation is no longer the constraint. Analytics is. As modalities grow more complex, the question is no longer what can be built—but what can be measured, characterized, and defended. The ability to generate insight is now pacing the ability to deliver therapies […]

TEDCO Invests in ICaPath

Maryland-based company pioneering a first-in-class cancer immunotherapy COLUMBIA, Md., — TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 Venture Funds investment in ICaPath located in Baltimore, Md. The Venture Fund is dedicated to growing the next generation of early-stage businesses in Maryland. “With TEDCO’s support, we will continue to unlock the full power of immunotherapy […]